Hubei Jumpcan Pharmaceutical Co., Ltd.
600566
Classement en actions
#4336
Hubei Jumpcan Pharmaceutical Co., Ltd. is a Chinese enterprise dedicated to the... Hubei Jumpcan Pharmaceutical Co., Ltd. is a Chinese enterprise dedicated to the full spectrum of pharmaceutical operations, encompassing research, development, production, and marketing. The company's product lines include both traditional Chinese and Western medicines, as well as daily-use chemical products incorporating traditional Chinese medicine, and health supplements rooted in Chinese medical practices. Their diverse range of Chinese and Western pharmaceuticals addresses a wide array of therapeutic areas, such as pediatric care, women's health, respiratory conditions, digestive disorders, and geriatric medicine. Additionally, their development pipeline covers treatments for detoxification, nervous system ailments, anti-infective agents, cardiovascular issues, pain relief, nutritional deficiencies, musculoskeletal problems, and blood clotting management. Beyond medicinal products, Jumpcan also manufactures oral and skin care items. The company's Chinese medicine-based health products are designed to provide benefits like fatigue reduction, anti-aging effects, antioxidant support, and immune system boosting. Headquartered in Taixing, China, the company adopted its current name, Hubei Jumpcan Pharmaceutical Co., Ltd., in March 2015, having previously operated as Hubei Hongcheng General Machinery Co., Ltd.
Prix de l'action
$3.87
Capitalisation boursière
$3.57B
Changement (1 jour)
-1.64%
Changement (1 an)
9.08%
Pays
CN
Échange Hubei Jumpcan Pharmaceutical Co., Ltd. (600566)
Catégorie
Healthcare
Historique du prix de l'action pour Hubei Jumpcan Pharmaceutical Co., Ltd. (600566)
Prix de clôture le plus élevé : $3.88 le 2026-10-01
Prix de clôture le plus bas : $1.83 le 2001-08-01
Prix de clôture le plus bas : $1.83 le 2001-08-01
Historique du prix de l'action de Hubei Jumpcan Pharmaceutical Co., Ltd. de 2001 à 2026
Performance annuelle du prix de l'action
| Année | Performance |
|---|---|
| 2026 (TTM) | -0.92% |
| 2025 | -6.01% |
| 2024 | -7.54% |
| 2023 | 5.98% |
| 2022 | 19.52% |
| 2021 | 7.70% |
| 2020 | -0.23% |
| 2019 | -36.14% |
| 2018 | -11.48% |
| 2017 | 30.24% |
| 2016 | 6.41% |
| 2015 | 21.52% |
| 2014 | 19.31% |
| 2013 | 181.02% |
| 2012 | -23.28% |
| 2011 | -14.91% |
| 2010 | 35.00% |
| 2009 | 112.48% |
| 2008 | -40.87% |
| 2007 | 93.88% |
| 2006 | 13.17% |
| 2005 | -20.02% |
| 2004 | -24.12% |
| 2003 | -38.44% |
| 2002 | -26.55% |
| 2001 | 0.00% |
Prix de l'action pour des entreprises similaires ou concurrentes
| Entreprise | Prix de l'action | Variation 1a% | Pays |
|---|---|---|---|
| $171.67 | - |
DE
|
|
| $165.31 | 23.62% |
DE
|
|
| $40.45 | 43.11% |
JP
|
|
| $224.81 | 31.28% |
CH
|
|
| $18.43 | -4.03% |
IN
|
